Additional file 2: of Targeting myeloid-inflamed tumor with anti-CSF-1R antibody expands CD137+ effector T-cells in the murine model of pancreatic cancer

Figure S2. PD-1 + CD137+ expression increases when αCSF-1R is administered before and after GVAX vaccination in combination with αPD-1. Representative flow cytometry dot plots of PD-1 and CD137 expression amongst CD8+ and CD4+ T-cells between the different treatment regimens containing αCSF-1R, GVAX and αPD-1. (PNG 269 kb